Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jaka Biotech CoBJSE:920165 20 PB Ratio is 3.14 as of Aug. 31, 2026, which is 2% below its 10-year median of 3.19. GuruFocus rates BJSE:920165 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,904 Consumer Packaged Goods companies, Jaka Biotech Co ranks worse than 79.94% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-31), Jaka Biotech Co's share price is ¥36.82. Jaka Biotech Co's Book Value per Share for the quarter that ended in Jun. 2026 was ¥11.73. Hence, Jaka Biotech Co's PB Ratio of today is 3.14.
The historical rank and industry rank for Jaka Biotech Co's PB Ratio or its related term are showing as below:
BJSE:920165'
s PB Ratio Range Over the Past 10 Years
Min: 3.14 Med: 3.19 Max: 3.28
Current: 3.14
During the past 4 years, Jaka Biotech Co's highest PB Ratio was 3.28. The lowest was 3.14. And the median was 3.19.
BJSE:920165's PB Ratio is ranked worse than 79.94% of 1904
companies
in the Consumer Packaged Goods industry
Industry Median: 1.42
vs BJSE:920165: 3.14
During the past 12 months, Jaka Biotech Co's average Book Value Per Share Growth Rate was 19.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 17.00% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Jaka Biotech Co was 17.00% per year. The lowest was 17.00% per year. And the median was 17.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Jaka Biotech Co PB Ratio Related Terms
Jaka Biotech Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Jaka Biotech Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Jaka Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jaka Biotech Co PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Jaka Biotech Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Jaka Biotech Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Jaka Biotech Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Jaka Biotech Co (BJSE:920165) has a PB Ratio of 3.14 as of Aug. 31, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Jaka Biotech Co and its competitors. This is near median its historical median of 3.19. Over the past decade, Jaka Biotech Co's PB Ratio has ranged from 3.14 to 3.28. According to the industry distribution chart, Jaka Biotech Co ranks #1522 out of 1904 companies in the Consumer Packaged Goods industry, placing it in the top 79.9%.
Is Jaka Biotech Co's PB Ratio too high?
Jaka Biotech Co's current PB Ratio of 3.14 is near median its 10-year median of 3.19. Over the past 10 years, this metric has ranged from a low of 3.14 to a high of 3.28. The Consumer Packaged Goods industry median PB Ratio is 1.42. Jaka Biotech Co's value of 3.14 is 121.1% above this industry median. Based on the distribution chart, Jaka Biotech Co ranks #1522 out of 1904 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Jaka Biotech Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Jaka Biotech Co's PB Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Jaka Biotech Co ranks #1522 out of 1904 companies for PB Ratio. This places Jaka Biotech Co in the lower half of its industry. The industry median PB Ratio is 1.42. Jaka Biotech Co's value of 3.14 is 121.1% above this benchmark. Historically, Jaka Biotech Co's own PB Ratio has ranged from 3.14 to 3.28 over the past decade. While the company's 10-year median is 3.19 vs. the industry median of 1.42, Jaka Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.42, based on 1,904 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jaka Biotech Co's current PB Ratio of 3.14 is 121.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Jaka Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jaka Biotech Co's current PB Ratio is 3.14, which is near median its own 10-year median of 3.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jaka Biotech Co stock overvalued right now?
Jaka Biotech Co (BJSE:920165) has a current PB Ratio of 3.14. The current PB Ratio is 3.14, which is near median its 10-year median of 3.19 and 121.1% above the Consumer Packaged Goods industry median of 1.42. Jaka Biotech Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Jaka Biotech Co (BJSE:920165), the current PB Ratio is 3.14 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jaka Biotech Co Ltd is engaged in the research, development, production and sales of cosmetic functional ingredients. Its operations include pharmaceutical manufacturing, testing and inspection services, manufacturing and sales of specialty chemical products, and bio-based materials.
20GF Score
Get the complete analysis for BJSE:920165
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920165 has been successfully added to your 
